Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • General Meetings

Corporate Governance

Corporate Governance

As a company listed on NASDAQ OMX Copenhagen, Veloxis must be in compliance with Danish securities law and it is Veloxis' intent to be guided by the Corporate Governance Recommendations designated by NASDAQ OMX Copenhagen. NASDAQ OMX Copenhagen has on a comply or explain basis designated the Danish Recommendations on Corporate Governance (revised November 2017) prepared by the Danish Committee on Corporate Governance.

Veloxis' corporate governance practice, position and our compliance with the recommendations are found in this section.

Governance Statements
Statutory Corporate Governance Report for 2018, cf. art. 107b of the Danish Financial Statements Act 1.4 MB
Statutory Corporate Governance Report for 2017, cf. art. 107b of the Danish Financial Statements Act 718.5 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2016) 681.6 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2015) 496.8 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2014) 500.2 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2013) 401.4 KB
Veloxis Corporate Governance 2011 - English 518.5 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 671.1 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2011) 694.7 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 500.9 KB

Submenu - Corporate Governance

  • Corporate Governance
  • Governance Documents
  • Risk Management
  • Reporting Compliance
  • Violations and Concerns
  • Whistleblower Policy
  • Guidelines for Reported Employees

Latest News & Releases

Jun 22, 2020
Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program
Feb 17, 2020
Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020

View All

© 2021 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer